Conjugation and Labeling Services Market: Focus on Protein Labeling, Peptide Labeling, Small Molecule Conjugation and Antibody Conjugation: Distribution by Type of Molecule Supported (Proteins, Peptides, Small Molecules, Antibodies and Other Molecules), Type of Molecular Conjugate / Label (Polymers, Haptens, Enzymes, Fluorescent Tags, Bead Coupling / Particle Conjugates, Quantum Dots, Isotopes and Other Molecular Conjugates / Labels), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, 2023-2035
The global conjugation and labelling services market is expected to reach USD 9,000 million in 2023 anticipated to grow at a CAGR of 10.2% during the forecast period 2023-2035.
The process of conjugation involves the creation of a stable hybrid by combining distinct entities, commonly incorporating molecules like proteins, antibodies, peptides, or small molecules. This amalgamation can occur through various methods, including the utilization of haptens, enzymes, isotopes, fluorescent tags, carrier proteins, polymers, particle conjugates, and photoreactive molecules. Particularly within the domain of bioconjugation, at least one of these entities involved is a biomolecule, such as a protein or antibody. The synergy achieved through these conjugates and biomolecules yields unique functionalities that are often challenging to attain individually. These functionalities offer enhancements in various aspects such as membrane permeability, target specificity, circulation time, and overall improvement in pharmacokinetic properties.
An important facet of bioconjugation arises when these modifications facilitate detection, either directly or indirectly, in bioimaging and immunoassays. This facet is commonly referred to as biomolecule labeling. In current industrial applications, a wide array of labeling approaches, encompassing fluorescent and isotopic labeling, are employed for protein profiling. These methods enable the quantification of compounds and the visualization of intricate biological processes.
In recent years, the pharmaceutical industry has increasingly recognized the potential of these complex entities across diverse applications. These applications span from the development of conjugated drug therapeutics and advanced drug delivery systems to disease diagnosis, the creation of diagnostic tools, and high-throughput screening.
The market for conjugation and labeling services has experienced substantial growth, owing to the escalating demand for conjugated biomolecules in research and development endeavors. Numerous global entities are actively engaged in providing proficient antibody conjugation services specifically for research purposes. This burgeoning demand, coupled with the multifaceted applications, anticipates significant expansion in the conjugation and labeling services market in the foreseeable future.
Report Coverage
The process of conjugation involves the creation of a stable hybrid by combining distinct entities, commonly incorporating molecules like proteins, antibodies, peptides, or small molecules. This amalgamation can occur through various methods, including the utilization of haptens, enzymes, isotopes, fluorescent tags, carrier proteins, polymers, particle conjugates, and photoreactive molecules. Particularly within the domain of bioconjugation, at least one of these entities involved is a biomolecule, such as a protein or antibody. The synergy achieved through these conjugates and biomolecules yields unique functionalities that are often challenging to attain individually. These functionalities offer enhancements in various aspects such as membrane permeability, target specificity, circulation time, and overall improvement in pharmacokinetic properties.
An important facet of bioconjugation arises when these modifications facilitate detection, either directly or indirectly, in bioimaging and immunoassays. This facet is commonly referred to as biomolecule labeling. In current industrial applications, a wide array of labeling approaches, encompassing fluorescent and isotopic labeling, are employed for protein profiling. These methods enable the quantification of compounds and the visualization of intricate biological processes.
In recent years, the pharmaceutical industry has increasingly recognized the potential of these complex entities across diverse applications. These applications span from the development of conjugated drug therapeutics and advanced drug delivery systems to disease diagnosis, the creation of diagnostic tools, and high-throughput screening.
The market for conjugation and labeling services has experienced substantial growth, owing to the escalating demand for conjugated biomolecules in research and development endeavors. Numerous global entities are actively engaged in providing proficient antibody conjugation services specifically for research purposes. This burgeoning demand, coupled with the multifaceted applications, anticipates significant expansion in the conjugation and labeling services market in the foreseeable future.
Report Coverage
- An executive summary of the key insights captured in our research. It offers a high-level view on the current state of conjugation and labeling services market and its likely evolution in the mid-long term.
- A general overview of conjugation and labeling of biomolecules, highlighting the various advantages of biomolecule conjugation and labeling. It also provides details on the different types of biomolecular conjugates and labels. Additionally, it concludes with a discussion on various applications of conjugated and labeled biomolecules in the biotechnology and pharmaceutical industry.
- Detailed assessment of the overall market landscape of the companies offering conjugation and labeling services, based on several relevant parameters, such as year of establishment, company size, location of headquarters, type of molecule(s) supported, type of molecular conjugate(s) / label(s) and conjugation service(s) offered.
- A detailed company competitiveness analysis of conjugation and labeling service providers based on company strength (in terms of years of experience and company size) and service strength (in terms of type of molecule(s) supported, type of molecular conjugate(s) / label(s) and conjugation service(s) offered).
- Detailed profiles of prominent players (shortlisted based on a proprietary criterion) offering conjugation and labeling services, located across North America, Europe and Asia-Pacific. Each profile features a brief overview of the company, recent developments and an informed future outlook.
- A detailed analysis of the various partnerships inked between stakeholders engaged in this domain, since 2018, covering acquisitions, service agreements, product development agreements, technology licensing agreements, and other relevant agreements.
- A detailed analysis of recent events (webinars / conferences / seminars / meetings / symposiums / summits) that were organized for stakeholders in the bioconjugation domain, based on several relevant parameters, such as year of event, event platform, type of event, geography, key focus areas, most active event organizers, active industry and non-industry players (in terms of number of speakers), seniority level of event speakers and geographical mapping of upcoming events.
- Detailed information on the affiliated trends, key drivers and challenges, under a reliable SWOT framework. The chapter includes a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall conjugation and labeling services market.
- A comprehensive market forecast and opportunity analysis, highlighting the future potential of the market till the year 2035. We have segregated the current and upcoming opportunity based on type of molecule supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate / label (polymers, haptens, enzymes, fluorescent tags, bead coupling / particle conjugates, quantum dots, isotopes and other molecular conjugates / labels), and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America).
- AltaBioscience
- Bachem
- Bio-Synthesis
- Cayman Chemical
- CliniSciences
- Eurogentec
- GBI
- Mimotopes
- Peptide Institute
- piCHEM
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Biomolecule Conjugation and Labeling
3.3. Types of Biomolecular Conjugates and Labels
3.4. Applications of Conjugated and Labeled Biomolecules
3.5. Concluding Remarks
4. CONJUGATION AND LABELING SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Conjugation and Labeling Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Type of Molecule(s) Conjugated / Labeled
4.2.6. Analysis by Type of Molecular Conjugate(s) / Label(s) Used
4.2.6.1. Analysis by Type of Enzyme(s) Used
4.2.6.2. Analysis by Type of Hapten(s) Used
4.2.7. Analysis by Conjugation Service(s) Offered
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis
5.4.1. Conjugation and Labeling Service Providers based in North America
5.4.2. Conjugation and Labeling Service Providers based in Europe
5.4.3. Conjugation and Labeling Service Providers based in Asia-Pacific
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. AltaBioscience
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook
6.3. Bachem
6.3.1. Company Overview
6.3.2. Recent Developments and Future Outlook
6.4. Bio-Synthesis
6.4.1. Company Overview
6.4.2. Recent Developments and Future Outlook
6.5. Cayman Chemical
6.5.1. Company Overview
6.5.2. Recent Developments and Future Outlook
6.6. CliniSciences
6.6.1. Company Overview
6.6.2. Recent Developments and Future Outlook
6.7. Eurogentec
6.7.1. Company Overview
6.7.2. Recent Developments and Future Outlook
6.8. GBI (formerly known as Goodwin Biotechnology)
6.8.1. Company Overview
6.8.2. Recent Developments and Future Outlook
6.9. Mimotopes
6.9.1. Company Overview
6.9.2. Recent Developments and Future Outlook
6.10. Peptide Institute
6.10.1. Company Overview
6.10.2. Recent Developments and Future Outlook
6.11. piCHEM
6.11.1. Company Overview
6.11.2. Recent Developments and Future Outlook
7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3. Conjugation and Labeling Services: Partnerships and Collaborations
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.3. Analysis by Year and Type of Partnership
7.3.4. Analysis by Type of Partner
7.3.5. Analysis by Year of Partnership and Type of Partner
7.3.6. Analysis by Type of Partnership and Type of Partner
7.3.7. Analysis by Location of Headquarters of Partner
7.3.8. Analysis by Type of Partnership and Location of Headquarters of Partner
7.3.9. Most Active Players: Analysis by Number of Partnerships
7.3.10. Analysis by Geography
7.3.10.1. Intercontinental and Intracontinental Deals
7.3.10.2. Local and International Deals
8. GLOBAL EVENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Conjugation and Labeling Services: Global Event Analysis
8.3.1. Analysis by Year of Event
8.3.2. Analysis by Event Platform
8.3.3. Analysis by Type of Event
8.3.4. Analysis by Year and Type of Event
8.3.5. Analysis by Geography
8.3.6. Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Area
8.3.7. Most Active Organizers: Analysis by Number of Events
8.4. Global Events: Speaker Analysis
8.4.1. Most Active Industry Players: Analysis by Number of Speakers
8.4.2. Most Active Non-Industry Players: Analysis by Number of Speakers
8.4.3. Analysis by Seniority Level of Event Speakers
8.5. Geographical Mapping of Upcoming Events
8.6. Concluding Remarks
9. SWOT ANALYSIS
9.1. Chapter Overview
9.2. Conjugation and Labeling Services: SWOT Analysis
9.2.1. Comparison of SWOT Factors
10. MARKET FORECAST AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions and Forecast Methodology
10.3. Global Conjugation and Labeling Services Market, 2023-2035
10.4. Conjugation and Labeling Services Market: Analysis by Type of Molecule
10.4.1. Conjugation and Labeling Services Market for Proteins, 2023-2035
10.4.2. Conjugation and Labeling Services Market for Antibodies, 2023-2035
10.4.3. Conjugation and Labeling Services Market for Peptides, 2023-2035
10.4.4. Conjugation and Labeling Services Market for Small Molecules, 2023-2035
10.4.5. Conjugation and Labeling Services Market for Other Molecules, 2023-2035
10.5. Conjugation and Labeling Services Market: Analysis by Type of Molecular Conjugate / Label
10.5.1. Conjugation and Labeling Services Market for Polymers, 2023-2035
10.5.2. Conjugation and Labeling Services Market for Haptens, 2023-2035
10.5.3. Conjugation and Labeling Services Market for Enzymes, 2023-2035
10.5.4. Conjugation and Labeling Services Market for Fluorescent Tags, 2023-2035
10.5.5. Conjugation and Labeling Services Market for Bead Coupling / Particle Conjugates, 2023-2035
10.5.6. Conjugation and Labeling Services Market for Quantum Dots, 2023-2035
10.5.7. Conjugation and Labeling Services Market for Isotopes, 2023-2035
10.5.8. Conjugation and Labeling Services Market for Other Molecular Conjugates / Labels, 2023-2035
10.6. Conjugation and Labeling Services Market: Analysis by Key Geographical Regions
10.6.1. Conjugation and Labeling Services Market in North America, 2023-2035
10.6.2. Conjugation and Labeling Services Market in Europe, 2023-2035
10.6.3. Conjugation and Labeling Services Market in Asia-Pacific, 2023-2035
10.6.4. Conjugation and Labeling Services Market in Middle East and North Africa, 2023-2035
10.6.5. Conjugation and Labeling Services Market in Latin America, 2023-2035
11. CONCLUSION
12. EXECUTIVE INSIGHTS
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Biomolecule Conjugation and Labeling
3.3. Types of Biomolecular Conjugates and Labels
3.4. Applications of Conjugated and Labeled Biomolecules
3.5. Concluding Remarks
4. CONJUGATION AND LABELING SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Conjugation and Labeling Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Type of Molecule(s) Conjugated / Labeled
4.2.6. Analysis by Type of Molecular Conjugate(s) / Label(s) Used
4.2.6.1. Analysis by Type of Enzyme(s) Used
4.2.6.2. Analysis by Type of Hapten(s) Used
4.2.7. Analysis by Conjugation Service(s) Offered
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis
5.4.1. Conjugation and Labeling Service Providers based in North America
5.4.2. Conjugation and Labeling Service Providers based in Europe
5.4.3. Conjugation and Labeling Service Providers based in Asia-Pacific
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. AltaBioscience
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook
6.3. Bachem
6.3.1. Company Overview
6.3.2. Recent Developments and Future Outlook
6.4. Bio-Synthesis
6.4.1. Company Overview
6.4.2. Recent Developments and Future Outlook
6.5. Cayman Chemical
6.5.1. Company Overview
6.5.2. Recent Developments and Future Outlook
6.6. CliniSciences
6.6.1. Company Overview
6.6.2. Recent Developments and Future Outlook
6.7. Eurogentec
6.7.1. Company Overview
6.7.2. Recent Developments and Future Outlook
6.8. GBI (formerly known as Goodwin Biotechnology)
6.8.1. Company Overview
6.8.2. Recent Developments and Future Outlook
6.9. Mimotopes
6.9.1. Company Overview
6.9.2. Recent Developments and Future Outlook
6.10. Peptide Institute
6.10.1. Company Overview
6.10.2. Recent Developments and Future Outlook
6.11. piCHEM
6.11.1. Company Overview
6.11.2. Recent Developments and Future Outlook
7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3. Conjugation and Labeling Services: Partnerships and Collaborations
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.3. Analysis by Year and Type of Partnership
7.3.4. Analysis by Type of Partner
7.3.5. Analysis by Year of Partnership and Type of Partner
7.3.6. Analysis by Type of Partnership and Type of Partner
7.3.7. Analysis by Location of Headquarters of Partner
7.3.8. Analysis by Type of Partnership and Location of Headquarters of Partner
7.3.9. Most Active Players: Analysis by Number of Partnerships
7.3.10. Analysis by Geography
7.3.10.1. Intercontinental and Intracontinental Deals
7.3.10.2. Local and International Deals
8. GLOBAL EVENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Conjugation and Labeling Services: Global Event Analysis
8.3.1. Analysis by Year of Event
8.3.2. Analysis by Event Platform
8.3.3. Analysis by Type of Event
8.3.4. Analysis by Year and Type of Event
8.3.5. Analysis by Geography
8.3.6. Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Area
8.3.7. Most Active Organizers: Analysis by Number of Events
8.4. Global Events: Speaker Analysis
8.4.1. Most Active Industry Players: Analysis by Number of Speakers
8.4.2. Most Active Non-Industry Players: Analysis by Number of Speakers
8.4.3. Analysis by Seniority Level of Event Speakers
8.5. Geographical Mapping of Upcoming Events
8.6. Concluding Remarks
9. SWOT ANALYSIS
9.1. Chapter Overview
9.2. Conjugation and Labeling Services: SWOT Analysis
9.2.1. Comparison of SWOT Factors
10. MARKET FORECAST AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions and Forecast Methodology
10.3. Global Conjugation and Labeling Services Market, 2023-2035
10.4. Conjugation and Labeling Services Market: Analysis by Type of Molecule
10.4.1. Conjugation and Labeling Services Market for Proteins, 2023-2035
10.4.2. Conjugation and Labeling Services Market for Antibodies, 2023-2035
10.4.3. Conjugation and Labeling Services Market for Peptides, 2023-2035
10.4.4. Conjugation and Labeling Services Market for Small Molecules, 2023-2035
10.4.5. Conjugation and Labeling Services Market for Other Molecules, 2023-2035
10.5. Conjugation and Labeling Services Market: Analysis by Type of Molecular Conjugate / Label
10.5.1. Conjugation and Labeling Services Market for Polymers, 2023-2035
10.5.2. Conjugation and Labeling Services Market for Haptens, 2023-2035
10.5.3. Conjugation and Labeling Services Market for Enzymes, 2023-2035
10.5.4. Conjugation and Labeling Services Market for Fluorescent Tags, 2023-2035
10.5.5. Conjugation and Labeling Services Market for Bead Coupling / Particle Conjugates, 2023-2035
10.5.6. Conjugation and Labeling Services Market for Quantum Dots, 2023-2035
10.5.7. Conjugation and Labeling Services Market for Isotopes, 2023-2035
10.5.8. Conjugation and Labeling Services Market for Other Molecular Conjugates / Labels, 2023-2035
10.6. Conjugation and Labeling Services Market: Analysis by Key Geographical Regions
10.6.1. Conjugation and Labeling Services Market in North America, 2023-2035
10.6.2. Conjugation and Labeling Services Market in Europe, 2023-2035
10.6.3. Conjugation and Labeling Services Market in Asia-Pacific, 2023-2035
10.6.4. Conjugation and Labeling Services Market in Middle East and North Africa, 2023-2035
10.6.5. Conjugation and Labeling Services Market in Latin America, 2023-2035
11. CONCLUSION
12. EXECUTIVE INSIGHTS
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
